EUVIMEDEUVIMED entdecken
EditorialKommentarRandomisierte kontrollierte Studie

Optimal treatment of acute uncomplicated type B aortic dissection: Will a randomized trial ever be conducted?

Keith D Calligaro

Journal of Vascular Surgery · 2023

DOI: 10.1016/j.jvs.2022.12.065 ↗

Kurz gefasst

Editorial in der Zeitschrift Journal of Vascular Surgery, 2023. Verfasst von Keith D Calligaro. Beteiligte Einrichtung: Section of Vascular Surgery, Pennsylvania Hospital, Philadelphia, PA. Hauptthemen laut MEDLINE: Aortic Aneurysm, Thoracic, Aortic Dissection, Blood Vessel Prosthesis Implantation, Endovascular Procedures. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 2 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Aortic Aneurysm, ThoracicAortic DissectionBlood Vessel Prosthesis ImplantationEndovascular ProceduresHumansAcute DiseaseRetrospective StudiesRisk FactorsTreatment OutcomeRandomized Controlled Trials as Topic

Autor:innen und Institutionen

  • Section of Vascular Surgery, Pennsylvania Hospital, Philadelphia, PA.

Zitieren

APA

Calligaro, K. D. (2023). Optimal treatment of acute uncomplicated type B aortic dissection: Will a randomized trial ever be conducted?. Journal of Vascular Surgery. https://doi.org/10.1016/j.jvs.2022.12.065

Vancouver

Calligaro KD. Optimal treatment of acute uncomplicated type B aortic dissection: Will a randomized trial ever be conducted?. Journal of Vascular Surgery. 2023. doi:10.1016/j.jvs.2022.12.065

BibTeX
@article{Calligaro2023,
  author = {Calligaro, Keith D},
  title = {Optimal treatment of acute uncomplicated type B aortic dissection: Will a randomized trial ever be conducted?},
  journal = {Journal of Vascular Surgery},
  year = {2023},
  doi = {10.1016/j.jvs.2022.12.065}
}
Kostenlos starten →